This is a firm fixed price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Gempharmatech LLC, a foreign-owned for-profit biotechnology company. The contract is for the development of a conditional knockout mouse line to support NICHD's research. The total ceiling value of the contract is $14,380.00 with a completion date of January 5, 2024. There is no set-aside...
This is a firm-fixed price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Gempharmatech LLC, a foreign-owned for-profit biotechnology company. The contract is for the delivery of conditional knockout mouse lines to support NICHD's research programs. The total ceiling value of the contract is $11,930, and the period of performance is through January 15, 2023....
This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a part of the National Institutes of Health (NIH), to Gempharmatech LLC, a biotechnology company that specializes in developing humanized animal models. The contract is for the provision of a conditional knock-out mouse line to support NICHD's research. The contract has a ceiling value of $17,225 and a period of performance ending on August 31, 2022. Gempharmatech LLC has...
This is a firm fixed-price federal contract award from the Veterans Integrated Service Network 12, a civilian agency, to Gempharmatech LLC, a foreign-owned for-profit biotechnology company. The contract is for the generation of PGP/MDR1A floxed live mice, a specialized mouse model, to support preclinical drug discovery and development research. The contract has a ceiling value of $13,509.55 and a completion date of March 14, 2025. Gempharmatech has previously received similar contract awards...
This is a $249,167.58 firm fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the National Institutes of Health (NIH), to Gempharmatech LLC, a foreign-owned for-profit biotech company. The contract is for the development of humanized mouse models for nicotinamide N-methyltransferase (NNMT) and sulfotransferase (SULT1A1) using CRISPR knock-in technology. The contractor will conduct biochemical testing of inhibitors and...
The National Institute on Aging (NIA), on behalf of the National Institute on Drug Abuse (NIDA), awarded a $25,098.00 firm fixed-price purchase order to Ingenious Targeting Laboratory Inc., a minority-owned, small disadvantaged business, for a Custom Conditional Gpnmb cDNA cassette Knockin mouse model. The purpose is to generate a Cre-inducible Gpnmb-diphtheria toxin receptor (DTR) knock-in mouse to study the role of GPNMB+ macrophages in skeletal muscle injury response and aging. The period...
This federal contract award is for a delivery order issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The prime contractor is Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The award, valued at $7,286.00, is for additional breeding and other services to support gene targeting,...
This firm-fixed-price purchase order contract, valued at $13,594.30, was awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Cyagen Biomodels LLC, a for-profit biotechnology company located in Santa Clara, California. The contract is for the generation of a TBX3 conditional knockout mouse strain to support biomedical research. No small business set-aside was used for this award. Cyagen Biomodels LLC specializes in...
This is a firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services, to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract, with a ceiling value of $67,700.00, is for the provision of genetically modified (GM) mice and rats to support...
This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Landy Bioresources, LLC, a minority-owned, woman-owned business. The contract is for transgenic mice services, mouse colony maintenance, genotyping, surgery, and other procedures, as requested by Jeffrey Kopp from NIDDK. The total ceiling value of the contract is $19,985.00 and the ultimate completion date is September 26, 2012. This contract...